theory clinical_94_2
imports Main

begin

typedecl entity
typedecl event

consts
  MEKInhibitor :: "entity ⇒ bool"
  Country :: "entity ⇒ bool"
  UnavailableIn :: "entity ⇒ entity ⇒ bool"
  Combination :: "entity ⇒ bool"
  Vemurafenib :: "entity ⇒ bool"
  UnavailableFor :: "entity ⇒ entity ⇒ bool"
  Results :: "entity ⇒ bool"
  Monotherapy :: "entity ⇒ bool"
  Yield :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  BetterThan :: "entity ⇒ entity ⇒ bool"
  NotApplicable :: "entity ⇒ bool"

(* Explanation 1: MEK inhibitors are unavailable in the patient's country *)
axiomatization where
  explanation_1: "∀x y. MEKInhibitor x ∧ Country y ⟶ UnavailableIn x y"

(* Explanation 2: If MEK inhibitors are unavailable in the patient's country, then the combination of vemurafenib and a MEK inhibitor is unavailable for the patient *)
axiomatization where
  explanation_2: "∀x y z. (MEKInhibitor x ∧ Country y ∧ UnavailableIn x y) ⟶ (Combination z ∧ Vemurafenib z ∧ MEKInhibitor x ⟶ UnavailableFor z x)"

(* Explanation 3: The combination of vemurafenib and a MEK inhibitor may yield better results than vemurafenib monotherapy, but this is not applicable if MEK inhibitors are unavailable in the patient's country *)
axiomatization where
  explanation_3: "∀x y z w. (Combination x ∧ Vemurafenib x ∧ MEKInhibitor y ∧ Results z ∧ Monotherapy w ∧ Yield e1 ∧ Agent e1 x ∧ Patient e1 z ∧ BetterThan z w) ∧ (MEKInhibitor y ∧ Country z ∧ UnavailableIn y z ⟶ NotApplicable x)"

theorem hypothesis:
  assumes asm: "Combination x ∧ Vemurafenib x ∧ MEKInhibitor y"
  (* Hypothesis: Combination vemurafenib and MEK inhibitor unavailable for patient *)
  shows "∀x y. Combination x ∧ Vemurafenib x ∧ MEKInhibitor y ⟶ UnavailableFor x y"
proof -
  (* From the premise, we have known information about the combination, vemurafenib, and MEK inhibitor. *)
  from asm have "Combination x ∧ Vemurafenib x ∧ MEKInhibitor y" by blast
  (* Explanation 1 states that MEK inhibitors are unavailable in the patient's country. *)
  (* Explanation 2 provides a logical relation: If MEK inhibitors are unavailable in the patient's country, then the combination of vemurafenib and a MEK inhibitor is unavailable for the patient. *)
  (* Using the logical relation Implies(A, B), we can infer that the combination is unavailable for the patient. *)
  then have "UnavailableFor x y" sledgehammer
  then show ?thesis <ATP>
qed

end
